Developing a Diagnostic Multivariable Prediction Model for Urinary Tract Cancer in Patients Referred with Haematuria: Results from the IDENTIFY Collaborative Study.
Bladder cancer
Haematuria
Prostate cancer
Renal cancer
Risk Calculator
Risk factors
Urinary tract cancer
Urothelial cancer
Journal
European urology focus
ISSN: 2405-4569
Titre abrégé: Eur Urol Focus
Pays: Netherlands
ID NLM: 101665661
Informations de publication
Date de publication:
11 2022
11 2022
Historique:
received:
23
03
2022
revised:
05
05
2022
accepted:
04
06
2022
pubmed:
28
6
2022
medline:
15
12
2022
entrez:
27
6
2022
Statut:
ppublish
Résumé
Patient factors associated with urinary tract cancer can be used to risk stratify patients referred with haematuria, prioritising those with a higher risk of cancer for prompt investigation. To develop a prediction model for urinary tract cancer in patients referred with haematuria. A prospective observational study was conducted in 10 282 patients from 110 hospitals across 26 countries, aged ≥16 yr and referred to secondary care with haematuria. Patients with a known or previous urological malignancy were excluded. The primary outcomes were the presence or absence of urinary tract cancer (bladder cancer, upper tract urothelial cancer [UTUC], and renal cancer). Mixed-effect multivariable logistic regression was performed with site and country as random effects and clinically important patient-level candidate predictors, chosen a priori, as fixed effects. Predictors were selected primarily using clinical reasoning, in addition to backward stepwise selection. Calibration and discrimination were calculated, and bootstrap validation was performed to calculate optimism. The unadjusted prevalence was 17.2% (n = 1763) for bladder cancer, 1.20% (n = 123) for UTUC, and 1.00% (n = 103) for renal cancer. The final model included predictors of increased risk (visible haematuria, age, smoking history, male sex, and family history) and reduced risk (previous haematuria investigations, urinary tract infection, dysuria/suprapubic pain, anticoagulation, catheter use, and previous pelvic radiotherapy). The area under the receiver operating characteristic curve of the final model was 0.86 (95% confidence interval 0.85-0.87). The model is limited to patients without previous urological malignancy. This cancer prediction model is the first to consider established and novel urinary tract cancer diagnostic markers. It can be used in secondary care for risk stratifying patients and aid the clinician's decision-making process in prioritising patients for investigation. We have developed a tool that uses a person's characteristics to determine the risk of cancer if that person develops blood in the urine (haematuria). This can be used to help prioritise patients for further investigation.
Sections du résumé
BACKGROUND
Patient factors associated with urinary tract cancer can be used to risk stratify patients referred with haematuria, prioritising those with a higher risk of cancer for prompt investigation.
OBJECTIVE
To develop a prediction model for urinary tract cancer in patients referred with haematuria.
DESIGN, SETTING, AND PARTICIPANTS
A prospective observational study was conducted in 10 282 patients from 110 hospitals across 26 countries, aged ≥16 yr and referred to secondary care with haematuria. Patients with a known or previous urological malignancy were excluded.
OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS
The primary outcomes were the presence or absence of urinary tract cancer (bladder cancer, upper tract urothelial cancer [UTUC], and renal cancer). Mixed-effect multivariable logistic regression was performed with site and country as random effects and clinically important patient-level candidate predictors, chosen a priori, as fixed effects. Predictors were selected primarily using clinical reasoning, in addition to backward stepwise selection. Calibration and discrimination were calculated, and bootstrap validation was performed to calculate optimism.
RESULTS AND LIMITATIONS
The unadjusted prevalence was 17.2% (n = 1763) for bladder cancer, 1.20% (n = 123) for UTUC, and 1.00% (n = 103) for renal cancer. The final model included predictors of increased risk (visible haematuria, age, smoking history, male sex, and family history) and reduced risk (previous haematuria investigations, urinary tract infection, dysuria/suprapubic pain, anticoagulation, catheter use, and previous pelvic radiotherapy). The area under the receiver operating characteristic curve of the final model was 0.86 (95% confidence interval 0.85-0.87). The model is limited to patients without previous urological malignancy.
CONCLUSIONS
This cancer prediction model is the first to consider established and novel urinary tract cancer diagnostic markers. It can be used in secondary care for risk stratifying patients and aid the clinician's decision-making process in prioritising patients for investigation.
PATIENT SUMMARY
We have developed a tool that uses a person's characteristics to determine the risk of cancer if that person develops blood in the urine (haematuria). This can be used to help prioritise patients for further investigation.
Identifiants
pubmed: 35760722
pii: S2405-4569(22)00129-8
doi: 10.1016/j.euf.2022.06.001
pii:
doi:
Types de publication
Observational Study
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1673-1682Subventions
Organisme : Medical Research Council
ID : MR/S00680X/1
Pays : United Kingdom
Organisme : Department of Health
Pays : United Kingdom
Investigateurs
Aasem Chaudry
(A)
Abhishek Sharma
(A)
Adam Bennett
(A)
Adnan Ahmad
(A)
Ahmed Abroaf
(A)
Ahmed Musa Suliman
(AM)
Aimee Lloyd
(A)
Alastair McKay
(A)
Albert Wong
(A)
Alberto Silva
(A)
Alexandre Schneider
(A)
Alison MacKay
(A)
Allen Knight
(A)
Alkiviadis Grigorakis
(A)
Amar Bdesha
(A)
Amy Nagle
(A)
Ana Cebola
(A)
Ananda Kumar Dhanasekaran
(AK)
Andraž Kondža
(A)
André Barcelos
(A)
Andrea Benedetto Galosi
(AB)
Andrea Ebur
(A)
Andrea Minervini
(A)
Andrew Russell
(A)
Andrew Webb
(A)
Ángel García de Jalón
(ÁG)
Ankit Desai
(A)
Anna Katarzyna Czech
(AK)
Anna Mainwaring
(A)
Anthony Adimonye
(A)
Arighno Das
(A)
Arnaldo Figueiredo
(A)
Arnauld Villers
(A)
Artur Leminski
(A)
Arvinda Chippagiri
(A)
Asim Ahmed Lal
(AA)
Asıf Yıldırım
(A)
Athanasios Marios Voulgaris
(AM)
Audrey Uzan
(A)
Aye Moh Moh Oo
(AMM)
Ayman Younis
(A)
Bachar Zelhof
(B)
Bashir Mukhtar
(B)
Ben Ayres
(B)
Ben Challacombe
(B)
Benedict Sherwood
(B)
Benjamin Ristau
(B)
Billy Lai
(B)
Brechtje Nellensteijn
(B)
Brielle Schreiter
(B)
Carlo Trombetta
(C)
Catherine Dowling
(C)
Catherine Hobbs
(C)
Cayo Augusto Estigarribia Benitez
(CAE)
Cédric Lebacle
(C)
Cherrie Wing Yin Ho
(CWY)
Chi-Fai Ng
(CF)
Chloe Mount
(C)
Chon Meng Lam
(CM)
Chris Blick
(C)
Christian Brown
(C)
Christopher Gallegos
(C)
Claire Higgs
(C)
Clíodhna Browne
(C)
Conor McCann
(C)
Cristina Plaza Alonso
(C)
Daniel Beder
(D)
Daniel Cohen
(D)
Daniel Gordon
(D)
Daniel Wilby
(D)
Danny Gordon
(D)
David Hrouda
(D)
David Hua Wu Lau
(DHW)
Dávid Karsza
(D)
David Mak
(D)
David Martin-Way
(D)
Denula Suthaharan
(D)
Dhruv Patel
(D)
Diego M Carrion
(DM)
Donald Nyanhongo
(D)
Edward Bass
(E)
Edward Mains
(E)
Edwin Chau
(E)
Elba Canelon Castillo
(E)
Elizabeth Day
(E)
Elsayed Desouky
(E)
Emily Gaines
(E)
Emma Papworth
(E)
Emrah Yuruk
(E)
Enes Kilic
(E)
Eoin Dinneen
(E)
Erika Palagonia
(E)
Evanguelos Xylinas
(E)
Faizan Khawaja
(F)
Fernando Cimarra
(F)
Florian Bardet
(F)
Francesca Kum
(F)
Francesca Peters
(F)
Gábor Kovács
(G)
Geroge Tanasescu
(G)
Giles Hellawell
(G)
Giovanni Tasso
(G)
Gitte Lam
(G)
Giuseppe La Montagna
(G)
Giuseppe Pizzuto
(G)
Gordan Lenart
(G)
Graeme MacLennan
(G)
Günal Özgür
(G)
Hai Bi
(H)
Hannah Lyons
(H)
Hannah Warren
(H)
Hashim Ahmed
(H)
Helen Simpson
(H)
Helena Burden
(H)
Helena Gresty
(H)
Hernado Rios Pita
(H)
Holly Clarke
(H)
Hosam Serag
(H)
Howard Kynaston
(H)
Hugh Crawford-Smith
(H)
Hugh Mostafid
(H)
Hugo Otaola-Arca
(H)
Hui Fen Koo
(HF)
Ibrahim Ibrahim
(I)
Idir Ouzaid
(I)
Ignacio Puche-Sanz
(I)
Igor Tomašković
(I)
Ilker Tinay
(I)
Iqbal Sahibzada
(I)
Isaac Thangasamy
(I)
Iván Revelo Cadena
(IR)
Jacques Irani
(J)
Jakub Udzik
(J)
James Brittain
(J)
James Catto
(J)
James Green
(J)
James Tweedle
(J)
Jamie Borrego Hernando
(JB)
Jamie Leask
(J)
Jas Kalsi
(J)
Jason Frankel
(J)
Jason Toniolo
(J)
Jay D Raman
(JD)
Jean Courcier
(J)
Jeevan Kumaradeevan
(J)
Jennifer Clark
(J)
Jennifer Jones
(J)
Jeremy Yuen-Chun Teoh
(JY)
John Iacovou
(J)
John Kelly
(J)
John P Selph
(JP)
Jonathan Aning
(J)
Jon Deeks
(J)
Jonathan Cobley
(J)
Jonathan Olivier
(J)
Jonny Maw
(J)
José Antonio Herranz-Yagüe
(JA)
Jose Ignacio Nolazco
(JI)
Jose Manuel Cózar-Olmo
(JM)
Joseph Bagley
(J)
Joseph Jelski
(J)
Joseph Norris
(J)
Joseph Testa
(J)
Joshua Meeks
(J)
Juan Hernandez
(J)
Juan Luis Vásquez
(JL)
Karen Randhawa
(K)
Karishma Dhera
(K)
Katarzyna Gronostaj
(K)
Kathleen Houlton
(K)
Kathleen Lehman
(K)
Kathryn Gillams
(K)
Kelvin Adasonla
(K)
Kevin Brown
(K)
Kevin Murtagh
(K)
Kiki Mistry
(K)
Kim Davenport
(K)
Kosuke Kitamura
(K)
Laura Derbyshire
(L)
Laurence Clarke
(L)
Lawrie Morton
(L)
Levin Martinez
(L)
Louise Goldsmith
(L)
Louise Paramore
(L)
Luc Cormier
(L)
Lucio Dell'Atti
(L)
Lucy Simmons
(L)
Luis Martinez-Piñeiro
(L)
Luis Rico
(L)
Luke Chan
(L)
Luke Forster
(L)
Lulin Ma
(L)
Madeline Moore
(M)
Maria Camacho Gallego
(MC)
Maria José Freire
(MJ)
Mark Emberton
(M)
Mark Feneley
(M)
Marta Antón-Juanilla
(M)
Marta Viridiana Muñoz Rivero
(MVM)
Matea Pirša
(M)
Matteo Tallè
(M)
Matthew Crockett
(M)
Matthew Liew
(M)
Matthew Trail
(M)
Max Peters
(M)
Meghan Cooper
(M)
Meghana Kulkarni
(M)
Michael Ager
(M)
Ming He
(M)
Mo Li
(M)
Mohamed Omran Breish
(M)
Mohamed Tarin
(M)
Mohammed Aldiwani
(M)
Mudit Matanhelia
(M)
Muhammad Pasha
(M)
Mustafa Kaan Akalın
(MK)
Nasreen Abdullah
(N)
Nathan Hale
(N)
Neha Gadiyar
(N)
Neil Kocher
(N)
Nicholas Bullock
(N)
Nicholas Campain
(N)
Nicola Pavan
(N)
Nihad Al-Ibraheem
(N)
Nikita Bhatt
(N)
Nishant Bedi
(N)
Nitin Shrotri
(N)
Niyati Lobo
(N)
Olga Balderas
(O)
Omar Kouli
(O)
Otakar Capoun
(O)
Pablo Oteo Manjavacas
(P)
Paolo Gontero
(P)
Paramananthan Mariappan
(P)
Patricio Garcia Marchiñena
(PG)
Paul Erotocritou
(P)
Paul Sweeney
(P)
Paula Planelles
(P)
Peter Acher
(P)
Peter C Black
(PC)
Peter K Osei-Bonsu
(PK)
Peter Østergren
(P)
Peter Smith
(P)
Peter-Paul Michiel Willemse
(PM)
Piotr L Chlosta
(PL)
Qurrat Ul Ain
(Q)
Rachel Barratt
(R)
Rachel Esler
(R)
Raihan Khalid
(R)
Ray Hsu
(R)
Remigiusz Stamirowski
(R)
Reshma Mangat
(R)
Ricardo Cruz
(R)
Ricky Ellis
(R)
Robert Adams
(R)
Robert Hessell
(R)
Robert J A Oomen
(RJA)
Robert McConkey
(R)
Robert Ritchie
(R)
Roberto Jarimba
(R)
Rohit Chahal
(R)
Rosado Mario Andres
(RM)
Rosalyn Hawkins
(R)
Rotimi David
(R)
Rustom P Manecksha
(RP)
Sachin Agrawal
(S)
Syed Sami Hamid
(SS)
Samuel Deem
(S)
Sanchia Goonewardene
(S)
Satchi Kuchibhotla Swami
(SK)
Satoshi Hori
(S)
Shahid Khan
(S)
Shakeel Mohammud Inder
(S)
Shanthi Sangaralingam
(S)
Shekhar Marathe
(S)
Sheliyan Raveenthiran
(S)
Shigeo Horie
(S)
Shomik Sengupta
(S)
Sian Parson
(S)
Sidney Parker
(S)
Simon Hawlina
(S)
Simon Williams
(S)
Simone Mazzoli
(S)
Slawomir Grzegorz Kata
(S)
Sofia Pinheiro Lopes
(S)
Sónia Ramos
(S)
Sonpreet Rai
(S)
Sophie Rintoul-Hoad
(S)
Sorcha O'Meara
(S)
Steve Morris
(S)
Stacey Turner
(S)
Stefano Venturini
(S)
Stephanos Almpanis
(S)
Steven Joniau
(S)
Sunjay Jain
(S)
Susan Mallett
(S)
Sven Nikles
(S)
None Shahzad
Sylvia Yan
(S)
Taeweon Lee
(T)
Taha Uçar
(T)
Tamsin Drake
(T)
Tarq Toma
(T)
Teresa Cabañuz Plo
(T)
Thierry Bonnin
(T)
Tim Muilwijk
(T)
Tim Wollin
(T)
Timothy Shun Man Chu
(TSM)
Timson Appanna
(T)
Tom Brophy
(T)
Tom Ellul
(T)
Tomas Austin
(T)
Tomaž Smrkolj
(T)
Tracey Rowe
(T)
Troy Sukhu
(T)
Trushar Patel
(T)
Tullika Garg
(T)
Turhan Çaşkurlu
(T)
Uros Bele
(U)
Usman Haroon
(U)
Víctor Crespo-Atín
(V)
Victor Parejo Cortes
(V)
Victoria Capapé Poves
(V)
Vincent Gnanapragasam
(V)
Vineet Gauhar
(V)
Vinnie During
(V)
Vivek Kumar
(V)
Vojtech Fiala
(V)
Wasim Mahmalji
(W)
Wayne Lam
(W)
Yew Fung Chin
(Y)
Yigit Filtekin
(Y)
Yih Chyn Phan
(Y)
Youssed Ibrahim
(Y)
Zachary A Glaser
(ZA)
Zainal Adwin Abiddin
(ZA)
Zijian Qin
(Z)
Zsuzsanna Zotter
(Z)
Zulkifli Zainuddin
(Z)
Informations de copyright
Copyright © 2022 The Authors. Published by Elsevier B.V. All rights reserved.